ONCOLOGUES
Live / Registered — Registered (as of 29 Mar 2022)
What this means for you
Registered since 29 Mar 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88900007
- Registration number
- 6688308
- Mark type
- Stylized text
- Filed
- 04 May 2020
- Registered
- 29 Mar 2022
- Attorney of record
- Devon E. White
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical product development services; Pharmaceutical product evaluation services; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development of pharmaceuticals for the treatment of cancer and oncological conditions; Research and development of vaccines and medicines; Technical research in the field of pharmaceutical studies; Development of computer platform technology, namely, development of cancer immunotherapy software platforms for manufacturing therapeutics; Consulting services for others in the field of design, planning, and implementation of clinical trials; Information technology platform as Service (PaaS) featuring computer software platforms for cancer diagnosis and analysis of cancer symptoms and cancer treatment, in the medical field; Electronic data storage; Providing a bioinformatics platform as a service (PAAS) featuring computer software platforms for sequence data analysis in the field of manufacturing therapeutics; Medical and scientific research information in the field of cell therapy; Scientific research and analysis for medical purposes in the field of cancer, oncology and clinical trials
Owner
- Oncogenuity, Inc., New York, NY, US
- Oncogenuity, Inc., New York, NY, US
Prosecution history
- 29 Mar 2022 — REGISTERED-SUPPLEMENTAL REGISTER
- 22 Feb 2022 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 18 Feb 2022 — ASSIGNED TO LIE
- 14 Feb 2022 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 14 Feb 2022 — EXAMINER'S AMENDMENT ENTERED
- 14 Feb 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 Feb 2022 — EXAMINERS AMENDMENT E-MAILED
- 14 Feb 2022 — EXAMINERS AMENDMENT -WRITTEN
- 12 Feb 2022 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 11 Feb 2022 — USE AMENDMENT ACCEPTED
- 27 Jan 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Jan 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Jan 2022 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 27 Jan 2022 — AMENDMENT TO USE PROCESSING COMPLETE
- 27 Jan 2022 — USE AMENDMENT FILED